Over the last years, respiratory diseases represent a clinical concern, being included among
the leading causes of death in the world due to the lack of effective lung therapies, mainly …

As an emerging cancer therapeutic target, non-apoptotic cell death such as ferroptosis,
necroptosis and pyroptosis, etc., has revealed significant potential in cancer treatment for …

Nanomedicines hold great potential in anticancer therapy by modulating the biodistribution
of nanomaterials and initiating targeted oxidative stress damage, but they are also limited by …

Autophagy triggered by reactive oxygen species (ROS) in photodynamic therapy (PDT)
generally exhibits an anti-apoptotic effect to promote cell survival. Herein, an innovative …

Recently, drug delivery systems based on nanotechnology have received great attention in
cancer therapeutics and diagnostics since they can not only improve the treatment efficacy …

With the rapid development of nanotechnology, inorganic nanomaterials (NMs) have been
widely applied in modern society. As human exposure to inorganic NMs is inevitable …

Over the past ten years, polymeric nanoparticles as promising anticancer drug vehicles have
been extensively explored in cancer chemotherapy.[1–5] These nanoparticles are …

Silica hybrid materials play an important role in improvement of novel progressive functional
nanomaterials. Study in silica hybrid functional materials is supported by growing interest in …

Cancer cell metabolism is reprogrammed to sustain the high metabolic demands of cell
proliferation. Recently, emerging studies have shown that mitochondrial metabolism is a …

Many diseases originate from alterations at nanoscale levels. Precise drug delivery should
be achieved not only at cell level, but also at organelle level to achieve maximum …